10 results  1 of 1 

1 Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis
Yun-Jin Hwang, Jung-Hyun Park, Du-Hyong Cho
J Korean Med Sci.2020;35(35):e289.  Published online 2020 August 5     DOI: http://dx.doi.org/10.3346/jkms.2020.35.e289
      
2 Exploring the beneficial role of telmisartan in sepsis-induced myocardial injury through inhibition of high-mobility group box 1 and glycogen synthase kinase-3β/nuclear factor-κB pathway
Yan Jin, Hong Wang, Jing Li, Minyan Dang, Wenzhi Zhang, Yan Lei, Hao Zhao
Korean J Physiol Pharmacol.2020;24(4):311-317.   Published online 2020 July 1     DOI: http://dx.doi.org/10.4196/kjpp.2020.24.4.311
      
3 Telmisartan Inhibits Nitric Oxide Production and Vessel Relaxation via Protein Phosphatase 2A-mediated Endothelial NO Synthase-Ser1179 Dephosphorylation
Du-Hyong Cho
J Korean Med Sci.2019;34(42):e266.  Published online 2019 October 1     DOI: http://dx.doi.org/10.3346/jkms.2019.34.e266
      
4 Telmisartan increases hepatic glucose production via protein kinase C ζ-dependent insulin receptor substrate-1 phosphorylation in HepG2 cells and mouse liver
Kae Won Cho, Du-Hyong Cho
Yeungnam Univ J Med.2018;36(1):26-35.   Published online 2018 December 20     DOI: http://dx.doi.org/10.12701/yujm.2019.00059
      
5 Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans
Soo Hyeon Bae, Wan-Su Park, Seunghoon Han, Gab-jin Park, Jongtae Lee, Taegon Hong, Sangil Jeon, Dong-Seok Yim
Korean J Physiol Pharmacol.2018;22(3):321-329.   Published online 2018 April 25     DOI: http://dx.doi.org/10.4196/kjpp.2018.22.3.321
      
6 Mixed–effects analysis of increased rosuvastatin absorption by coadministered telmisartan
Wan-Su Park, Dooyeon Jang, Seunghoon Han, Yim Dong-Seok
Transl Clin Pharmacol.2016;24(1):55-62.   Published online 2016 March 15     DOI: http://dx.doi.org/10.12793/tcp.2016.24.1.55
   
7 Serious adverse events during clinical trial for pharmacokinetic interaction between telmisartan and chlorthalidone in healthy Korean subjects: A case report
Sook Jin Seong, Young-Ran Yoon, Mi-sun Lim
Transl Clin Pharmacol.2015;23(2):46-48.   Published online 2015 December 15     DOI: http://dx.doi.org/10.12793/tcp.2015.23.2.46
   
8 The Effects of Antihypertensive Drugs on Bone Mineral Density in Ovariectomized Mice
Kwi Young Kang, Yoongoo Kang, Mirinae Kim, Youngkyun Kim, Hyoju Yi, Juryun Kim, Hae-Rin Jung, Sung-Hwan Park, Ho-Youn Kim, Ji Hyeon Ju, Yeon Sik Hong
J Korean Med Sci.2013;28(8):1139-1144.   Published online 2013 July 31     DOI: http://dx.doi.org/10.3346/jkms.2013.28.8.1139
      
9 Effects of Telmisartan Compared with Valsartan on Plasma Adiponectin Levels and Arterial Stiffness in Patients with Type 2 Diabetes - A Pilot Study
Soo Yeon Park, Sin Gon Kim, Juri Park, Yun Jeong Lee, Hee Young Kim, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi
Korean Diabetes J.2008;32(3):236-242.   Published online 2008 June 30     DOI: http://dx.doi.org/10.4093/kdj.2006.32.3.236
      
10 A Clinical Study on Anti-Hypertensive Effect and Safety of Telmisartan (Micardis ) in Mild to Moderate Hypertensive Patients
Young Won Yoon, Byoung Kwon Lee, Ki Hyun Byun, Dong Hoon Choi, Shinki Ahn, Jong Won Ha, Yangsoo Jang, Namsik Chung, Won Heum Shim, Seung Yeon Cho, Sung Soon Kim
Korean Circ J.2000;30(10):1264-1270.   Published online 2000 October 31     DOI: http://dx.doi.org/10.4070/kcj.2000.30.10.1264
      

 1 of 1